ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "2023 Will Be a Big Year for U.S. Healthcare M&A"
Episode Synopsis
Today we're looking at the biggest trends in U.S. Healthcare M&A as discussed at the recently held J.P. Morgan Healthcare Conference.
“We can expect this to be a big year for M&A for Pharmaceutical and medical device companies,” says our guest Rebecca Wenzel, a senior reporter for Mergermarket. “They are sitting on piles of cash that they’re ready to deploy, though one of the differences we’ll see is that they’re going to be more selective about their roster of assets and assets will be met with more due diligence.”
Listen to learn about:
The rise of bolt-on deals in Biopharma and medical devices
Expected wave of Healthcare IT deals at reset valuations
Consolidation in private practice management
How financing challenges are affecting deals
Dealcast is presented by Mergermarket and SS&C Intralinks.
“We can expect this to be a big year for M&A for Pharmaceutical and medical device companies,” says our guest Rebecca Wenzel, a senior reporter for Mergermarket. “They are sitting on piles of cash that they’re ready to deploy, though one of the differences we’ll see is that they’re going to be more selective about their roster of assets and assets will be met with more due diligence.”
Listen to learn about:
The rise of bolt-on deals in Biopharma and medical devices
Expected wave of Healthcare IT deals at reset valuations
Consolidation in private practice management
How financing challenges are affecting deals
Dealcast is presented by Mergermarket and SS&C Intralinks.
More episodes of the podcast The Real Deal
H1 2024 M&A Trends: A Data-Driven Forecast
16/02/2024
In God we trust